DARE
Dare Bioscience·NASDAQ
--
--(--)
--
--(--)
6.32 / 10
Outperform
Analyst sentiment is bullish with a 100% strong-buy rating from one analyst, and fund-flow metrics are strong (7.15/10). Yet, the fund-flow patterns show negative trends at all scales (overall, block, small, medium, large, extra-large), hinting at short-term outflows despite the high score. This divergence between sentiment and flow dynamics underscores volatility and the importance of monitoring capital movements for confirmation.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-02
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for DARE?
- DARE holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.32/10 (Outperform).
